G. Walmsley Graham's Net Worth
-$32.9 Million
Who is G. Walmsley Graham?
G. Walmsley Graham does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Lifesci Acquisition II Corp., ALX ONCOLOGY HOLDINGS INC, Akero Therapeutics, Inc., and Olema Pharmaceuticals, Inc..
SEC CIK
G. Walmsley Graham's CIK is 0001777517
Past Insider Trading and Trends
2020 was G. Walmsley Graham's most active year for acquiring shares with 15 total transactions. G. Walmsley Graham's most active month to acquire stocks was the month of May. 2020 was G. Walmsley Graham's most active year for disposing of shares, totalling 3 transactions. G. Walmsley Graham's most active month to dispose stocks was the month of May. 2020 saw G. Walmsley Graham paying a total of $58,416,236.28 for 8,810,783 shares, this is the most they've acquired in one year. In 2020 G. Walmsley Graham cashed out on 4,689,776 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lifesci Acquisition II Corp. (SNCE) Snapshot price: $5.66
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +2.05% | 20K |
$76.00 | $1,520,000.00 | 0.99M |
Dec 14
| |||
Form 4
| +5,493.76% | 3.08M |
$19.00 | $18,525,000.00 | 3.14M |
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.29% | 100K |
$19.83 | $1,982,940.00 | 800K |
Dec 8
| |||
Form 4
| +16.67% | 100K |
$16.95 | $1,694,565.00 | 700K |
Nov 30 - Dec 1
| |||
Form 4
| +4.35% | 25K |
$42.06 | $1,051,475.00 | 600K |
Aug 8
| |||
Form 4
| +10.58% | 55K |
$42.95 | $2,362,234.00 | 575K |
Jul 28 - Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4/A
|
∞
| 520K |
$29.69 | $15,440,000.00 | 520K |
Sep 19 - May 19
| |||
Form 4
|
∞
| 520K |
$29.69 | $15,440,000.00 | 520K |
May 19 - Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 2.17K |
$19.97 | $43,294.96 | 2.17K |
Nov 8 - Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Olema Pharmaceuticals, Inc. (OLMA) Snapshot price: $15.345
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +55.17% | 640K |
$10.74 | $6,871,279.47 | 1.8M |
Sep 12 - Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 3.74M |
$19.00 | $22,040,000.00 | 3.74M |
Nov 23
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1 - Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||